The pricing policy of Cyprus is included in the provisions of Part VII of Chapter C of the Medicines for Human Use (control of Quality, Supply and Pricing) Law of 2001 (70 (I) / 2001), as well as in the provisions of the relevant Ministerial Notices and Decress issued by the Minister of Health.
The main role of the pricing policy is to determine the prices of medicinal products by comparing the prices in reference countries, or by calculation, up to 80% of the price of the existing reference medicines in the price list.
Special provisions are included in the legislation protecting against reductions in the prices of cheap medicines, in order to ensure their adequate supply in the market, as well as provisions for the liberalisation of the prices of non-prescription medicines (OTC) in order to strengthen the competition.